Genotyping Assay Market Size, Share, By Offerings (Reagents & Kits, Instruments, Software, and Services), Techniques (Microarray, DNA Sequencing, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, and Others), Application (Genetic Disease Diagnosis, Forensic Analysis, Pharmacogenomics, Agriculture, and Others), End-User (Diagnostics & Research Laboratories, Academic Institutes, Pharmaceutical & Biotechnological Companies, and Others), and Region - Trends, Analysis, and Forecast till 2035

By region, the genotyping assay market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America is the dominating region for the genotyping assay market due the presence of well-established healthcare infrastructure, high healthcare awareness and increasing prevalence of chronic diseases. The major biopharmaceutical companies and sequencing services are present in this region, resulting to drive Genotyping Assay market share growth.

Europe is the second-largest share in genotyping assay market. The factors such as the proliferation of academic institutes, increased healthcare infrastructure and rising demand for the personalized therapy resulting to drive genotyping assay market. Germany and U.K. genotyping market was the fastest-growing market in the European region.